Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Daniil Spector

Showing results (1-10 of 8) with videos related to

Pageof 1
Sort By:
International Journal of Molecular Sciences|December 11, 2022
Recent Advances in Light-Controlled Activation of Pt(IV) ProdrugsDaniil Spector, Kirill Pavlov, Elena Beloglazkina, et al.
International Journal of Molecular Sciences|April 30, 2021
Pt(IV) Prodrugs with NSAIDs as Axial LigandsDaniil Spector, Olga Krasnovskaya, Kirill Pavlov, et al.
International Journal of Molecular Sciences|December 5, 2020
Metals in Imaging of Alzheimer's DiseaseOlga Krasnovskaya, Daniil Spector, Alexander Zlobin, et al.
Dalton Transactions (Cambridge, England : 2003)|May 26, 2021
Alternative mechanism of action of the DNP Pt<sup>IV</sup> prodrug: intracellular cisplatin release and the mitochondria-mediated apoptotic pathwayOlga Krasnovskaya, Daniil Spector, Alexander Erofeev, et al.
Chemmedchem|January 10, 2025
Green Light Activated Dual-Action Pt(IV) Prodrug with Enhanced PDT ActivityDaniil Spector, Vladislav Bykusov, Yulia Isaeva, et al.
Spectrochimica Acta. Part A, Molecular and Biomolecular Spectroscopy|October 9, 2024
On the optical response of novel coumarin-fused NIR BODIPY dyes to X-raysNikita Lifanovsky, Daniil Spector, Anton Egorov, et al.
Dalton Transactions (Cambridge, England : 2003)|January 11, 2023
Biotinylated Pt(IV) prodrugs with elevated lipophilicity and cytotoxicityDaniil Spector, Alexander Erofeev, Peter Gorelkin, et al.
ACS Applied Bio Materials|May 2, 2024
Light-Responsive Pt(IV) Prodrugs with Controlled Photoactivation and Low Dark ToxicityDaniil Spector, Anna Bubley, Anastasia Zharova, et al.
Pageof 1

Showing results (1-10 of 8) with videos related to

Sort By:
Pageof 1
International Journal of Molecular Sciences|December 11, 2022
Recent Advances in Light-Controlled Activation of Pt(IV) ProdrugsDaniil Spector, Kirill Pavlov, Elena Beloglazkina, et al.
International Journal of Molecular Sciences|April 30, 2021
Pt(IV) Prodrugs with NSAIDs as Axial LigandsDaniil Spector, Olga Krasnovskaya, Kirill Pavlov, et al.
International Journal of Molecular Sciences|December 5, 2020
Metals in Imaging of Alzheimer's DiseaseOlga Krasnovskaya, Daniil Spector, Alexander Zlobin, et al.
Dalton Transactions (Cambridge, England : 2003)|May 26, 2021
Alternative mechanism of action of the DNP Pt<sup>IV</sup> prodrug: intracellular cisplatin release and the mitochondria-mediated apoptotic pathwayOlga Krasnovskaya, Daniil Spector, Alexander Erofeev, et al.
Chemmedchem|January 10, 2025
Green Light Activated Dual-Action Pt(IV) Prodrug with Enhanced PDT ActivityDaniil Spector, Vladislav Bykusov, Yulia Isaeva, et al.
Spectrochimica Acta. Part A, Molecular and Biomolecular Spectroscopy|October 9, 2024
On the optical response of novel coumarin-fused NIR BODIPY dyes to X-raysNikita Lifanovsky, Daniil Spector, Anton Egorov, et al.
Dalton Transactions (Cambridge, England : 2003)|January 11, 2023
Biotinylated Pt(IV) prodrugs with elevated lipophilicity and cytotoxicityDaniil Spector, Alexander Erofeev, Peter Gorelkin, et al.
ACS Applied Bio Materials|May 2, 2024
Light-Responsive Pt(IV) Prodrugs with Controlled Photoactivation and Low Dark ToxicityDaniil Spector, Anna Bubley, Anastasia Zharova, et al.
Pageof 1